CF Testing In Caucasians Planning Pregnancy Recommended By ACOG
This article was originally published in The Gray Sheet
Executive Summary
Genzyme Genetics plans to double manufacturing and shipping capabilities for its 87 Mutation Test, partially in response to recent guidelines recommending expanded cystic fibrosis screening.
You may also be interested in...
Abbott Gains Access To Celera R&D For Infectious Disease Assays
U.S. clinical lab evaluation of Celera Diagnostics' analyte-specific reagent hepatitis C test by year-end will be among the early milestones of the Applera unit's R&D and marketing agreement with Abbott
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.